IRIS
BONANNO, GIAMBATTISTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.718
Totale 23.718
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.718
Totale 23.718
Salva come PNG Salva come JPEG
Città #
Genova 18.775
Rapallo 2.780
Genoa 2.096
Bordighera 67
Totale 23.718
Salva come PNG Salva come JPEG
Nome #
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 155
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 153
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 150
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. 150
Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis 150
Activation of α6 GABAA receptors on depolarized cerebellar parallel fibers elicits glutamate release through anion channels 145
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 144
Subclassification of release-regulating a2-autoreceptors in human brain cortex. 143
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 142
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 141
Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F 140
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 137
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 135
A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals 134
Functional evidence for two native GABAA receptor subtypes in adult rat hippocampus and cerebellum. 132
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex 131
Heterologous carriers located on rat CNS nerve endings and their possible role in the modulation of transmitter release 131
Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms 130
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 129
Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels 128
Presynaptic receptors modulating transmitter release: physiological and pharmacological aspects 128
Release-regulating GABAB autoreceptors in rat cerebral cortex slices 127
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 127
GABAB autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions 126
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 125
Cellular mechanisms of the acute increase of glutamate release induced by nerve growth factor in rat cerebral cortex. 125
Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism 125
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 125
GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels 124
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 123
GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB 122
Serotonin-glutamate interactions in rat cerebellum: involvement of multiple 5-HT receptor subtypes 120
Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine 120
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 120
A novel type of GABA receptor in rat spinal cord? 120
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 119
NK-3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats 118
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 118
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 117
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 117
Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate 116
NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals. 115
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 115
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 114
Presynaptic receptors as potential targets of psychotropic drugs 114
Immunological imbalance in uncomplicated chronic alcoholism 113
Co-Existence of GABA and Glu Transporters in the Central Nervous System 113
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 113
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 113
The GABAergic-like system in the marine demosponge Chondrilla nucula 112
Role of external and internal calcium on heterocarrier-mediated transmitter release 112
Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra- and intraterminal calcium 112
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 112
Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis 112
Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration 111
Endocytosis of GABAB receptors modulates membrane excitability in the single-celled organism paramecium 111
Somatostatin release from rat cerebral cortex synaptosomes 111
GM1 ganglioside treatment promotes recovery of electrically-stimulated 3H-dopamine release in striatal slices from rats lesioned with kainic acid 110
Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis 110
Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a g-aminobutyric acidB (GABAB) receptor subtype. 109
Multiple mechanisms of transmitter release evoked by 'pathologically' elevated extracellular [K+]: involvement of transporter reversal and mitochondrial calcium 109
Role of calpain-1 in the early phase of experimental ALS 109
Selective block of rat and human neocortex GABA-B receptors regulating somatostatin release by a GABAB antagonist endowed with cognition enhancing activity 109
Release-regulating presynaptic heterocarriers 108
Presynaptic regulation of acetylcholine release in the CNS 108
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 107
GABA enhances acetylcholine release from hippocampal nerve endings through a mechanism blocked by a GABA uptake inhibitor 106
Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex 106
Facilitation of [3H]acetylcholine and [3H]5-hydroxytryptamine release from rat cerebral cortex synaptosomes by a factor extracted from the skin of the Australian frog Pseudophryne coriacea 106
Serotonin receptors regulating transmitter release 106
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 106
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 106
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 106
In vitro release of somatostatin from cerebral cortical slices: characterization of electrically evoked release 105
Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection 105
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 104
Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain 103
Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex 103
Neurosteroids may differentially affect the function of two native GABAA receptor subtypes in the rat brain. 102
Flow and static cytometries 102
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 101
Modulation of endogenous and radiolabeled dopamine release by acetylcholine 100
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 100
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus 100
Coexistence of more than one neurotransmitter uptake system on the same nerve terminal in the brain 99
Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons 99
γ-Aminobutyric acidB receptors mediate inhibition of somatostatin release from cerebrocortex nerve terminals. 99
Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex 99
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 99
Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes 99
Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synapticplasticity, and visual functions in a mouse model of Down syndrome 99
Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum 98
The Synapsin domain E accelerates the exoendocytotic cycle of synaptic vesicles in cerebellar Purkinje cells. 98
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 98
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 97
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 96
Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABA(B) receptors 96
Carriers for GABA and noradrenaline uptake coexist on a same nerve terminal in rat hippocampus 96
Synapsin phosphorylation by SRC tyrosine kinase enhances SRC activity in synaptic vesicles 95
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 95
Totale 11.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.913
article - articoli 43.355
book - libri 676
conference - conferenze 16.797
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.085
Totale 127.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019922 0 0 0 0 0 0 0 0 0 0 517 405
2019/20206.336 213 163 306 332 501 647 943 368 532 1.225 850 256
2020/20211.686 103 157 140 98 110 141 116 181 173 167 140 160
2021/20223.474 59 235 200 473 114 259 169 900 145 297 178 445
2022/20233.347 329 238 55 345 550 566 16 239 597 22 330 60
2023/20241.652 90 267 61 237 151 431 135 97 95 79 9 0
Totale 24.334